TY - JOUR
T1 - [Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation].
AU - Majhail, Navneet S.
AU - Rizzo, J. Douglas
AU - Lee, Stephanie J.
AU - Aljurf, Mahmoud
AU - Atsuta, Yoshiko
AU - Bonfim, Carmem
AU - Burns, Linda J.
AU - Chaudhri, Naeem
AU - Davies, Stella
AU - Okamoto, Shinichiro
AU - Seber, Adriana
AU - Socie, Gerard
AU - Szer, Jeff
AU - Van Lint, Maria Teresa
AU - Wingard, John R.
AU - Tichelli, Andre
AU - Center for International Blood, for International Blood
AU - American Society for Blood, Society for Blood
AU - European Group for Blood, Group for Blood
AU - Asia-Pacific Blood, Blood
AU - Bone Marrow Transplantation Society of Australia, Marrow Transplantation Society of Australia
AU - East Mediterrnean Blood, Mediterrnean Blood
AU - Sociedale Brasileira de Transplante de Medula Ossea (SBTMO), Brasileira de Transplante de Medula Ossea (SBTMO)
PY - 2014
Y1 - 2014
N2 - Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplantation exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.
AB - Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplantation exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.
UR - http://www.scopus.com/inward/record.url?scp=84906538926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84906538926&partnerID=8YFLogxK
M3 - Article
C2 - 24975331
AN - SCOPUS:84906538926
VL - 55
SP - 607
EP - 632
JO - [Rinsho ketsueki] The Japanese journal of clinical hematology
JF - [Rinsho ketsueki] The Japanese journal of clinical hematology
SN - 0485-1439
IS - 6
ER -